These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 27782069)

  • 1. What Is Breast in the Bone?
    Shemanko CS; Cong Y; Forsyth A
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation.
    Sutherland A; Forsyth A; Cong Y; Grant L; Juan TH; Lee JK; Klimowicz A; Petrillo SK; Hu J; Chan A; Boutillon F; Goffin V; Egan C; Tang PA; Cai L; Morris D; Magliocco A; Shemanko CS
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26586670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin receptor in breast cancer: marker for metastatic risk.
    Shemanko CS
    J Mol Endocrinol; 2016 Nov; 57(4):R153-R165. PubMed ID: 27658959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.
    Trinkaus M; Ooi WS; Amir E; Popovic S; Kalina M; Kahn H; Singh G; Gainford MC; Clemons M
    Oncol Rep; 2009 May; 21(5):1153-9. PubMed ID: 19360288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer metastasis to the bone: mechanisms of bone loss.
    Chen YC; Sosnoski DM; Mastro AM
    Breast Cancer Res; 2010; 12(6):215. PubMed ID: 21176175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin-β promotes breast cancer bone metastasis colonization and osteolytic outgrowth.
    Wang X; Zhang T; Zheng B; Lu Y; Liang Y; Xu G; Zhao L; Tao Y; Song Q; You H; Hu H; Li X; Sun K; Li T; Zhang Z; Wang J; Lan X; Pan D; Fu YX; Yue B; Zheng H
    Nat Cell Biol; 2024 Sep; 26(9):1597-1612. PubMed ID: 39147874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.
    Strazic-Geljic I; Guberovic I; Didak B; Schmid-Antomarchi H; Schmid-Alliana A; Boukhechba F; Bouler JM; Scimeca JC; Verron E
    Biochem Pharmacol; 2016 Sep; 116():11-21. PubMed ID: 27378505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
    Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
    BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling.
    Wang J; Rouse C; Jasper JS; Pendergast AM
    Sci Signal; 2016 Feb; 9(413):ra12. PubMed ID: 26838548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.
    Min Y; Ren X; Vaught DB; Chen J; Donnelly E; Lynch CC; Lin PC
    Cancer Res; 2010 Apr; 70(7):2819-28. PubMed ID: 20233869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.
    Das S; Samant RS; Shevde LA
    J Biol Chem; 2011 Mar; 286(11):9612-22. PubMed ID: 21169638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.
    Lynch CC
    Bone; 2011 Jan; 48(1):44-53. PubMed ID: 20601294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA; Edwards JR; Martin TJ; Mundy GR
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
    Guise TA; Mohammad KS; Clines G; Stebbins EG; Wong DH; Higgins LS; Vessella R; Corey E; Padalecki S; Suva L; Chirgwin JM
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6213s-6216s. PubMed ID: 17062703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
    Marino S; Bishop RT; Logan JG; Mollat P; Idris AI
    Cancer Lett; 2017 Dec; 410():180-190. PubMed ID: 28965856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
    Guise TA; Chirgwin JM
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer metastasis to bone: it is not all about PTHrP.
    Bendre M; Gaddy D; Nicholas RW; Suva LJ
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S39-45. PubMed ID: 14600591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
    Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
    Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
    Siclari VA; Mohammad KS; Tompkins DR; Davis H; McKenna CR; Peng X; Wessner LL; Niewolna M; Guise TA; Suvannasankha A; Chirgwin JM
    Breast Cancer Res; 2014 Dec; 16(6):458. PubMed ID: 25439669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.